GlassScriptPhysician profile
Miguel A Rivera
NPI 1699860122
$3,099.83
in general payments reported to CMS, 2019-2025
22 companies · $903 in 2025
The $903 reported for 2025 was more than what 79% of Otolaryngology/Facial Plastic Surgery providers received nationally (typical 2025 total: $305).
See the full distribution for Otolaryngology/Facial Plastic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $735 · 2020: $133 · 2021: $66.54 · 2022: $316 · 2023: $182 · 2024: $765 · 2025: $903.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,619 · Education: $231.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,619.19 |
| Education | $230.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $560.66 | 2022-2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $499.63 | 2020-2025 | Dupixent |
| Optinose US, INC. | $363.64 | 2019-2025 | |
| Acclarent, INC | $345.93 | 2019-2023 | Trudi Nav Cable |
| Medtronic, INC. | $218.55 | 2022-2024 | Stealthstation S8 Platform |
| Aerin Medical INC. | $192.72 | 2019 | |
| Neurent Medical Limited | $179.87 | 2023-2024 | Neuromark Radiofrequency Console, Neuromark Device |
| Intersect Ent, INC. | $115.96 | 2019 | |
| Alk-Abello, INC | $107.84 | 2019-2021 | |
| Stryker Corporation | $107.66 | 2019 | |
| Amgen INC. | $83.12 | 2025 | Tezspire |
| Medtronic USA, INC. | $73.24 | 2020 | |
| Novartis Pharmaceuticals Corporation | $50.42 | 2021-2025 | |
| Genzyme Corporation | $39.87 | 2021-2022 | |
| Livanova USA, INC. | $30.60 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ars Pharmaceuticals Operations, INC. | $28.18 | 2025 | Neffy |
| Circassia INC. | $23.99 | 2024 | Niox |
| Smith+Nephew, INC. | $18.31 | 2025 | Tula |
| Merck Sharp & Dohme LLC | $17.66 | 2023 | |
| Integra Lifesciences Corporation | $16.04 | 2023 | Integra, Instruments-Orthopedic, Integra Duo |
| Hologic Sales and Service, LLC | $13.17 | 2022 | |
| Kaleo, INC. | $12.77 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Miguel Rivera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.